Clinicopathologic factors related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer An analysis of 2050 patients

被引:28
|
作者
Lai, Hung-Wen [1 ,2 ,3 ,4 ,6 ,11 ,12 ]
Huang, Ren-Hung [5 ,12 ]
Wu, Yu-Ting [10 ,14 ]
Chen, Chih-Jung [5 ,6 ,12 ]
Chen, Shou-Tung [1 ,2 ,3 ,12 ]
Lin, Ying-Jen [7 ,12 ]
Chen, Dar-Ren [1 ,2 ,3 ,12 ]
Lee, Chih-Wei [8 ,12 ]
Wu, Hwa-Koon [8 ,12 ]
Lin, Hui-Yu [9 ,13 ]
Kuo, Shou-Jen [2 ,3 ,12 ]
机构
[1] Changhua Christian Hosp, Endoscop & Oncoplast Breast Surg Ctr, Changhua, Taiwan
[2] Changhua Christian Hosp, Comprehens Breast Canc Ctr, 135 Nanxiao St, Changhua 500, Taiwan
[3] Changhua Christian Hosp, Dept Surg, Div Gen Surg, Changhua, Taiwan
[4] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[5] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[7] Changhua Christian Hosp, Tumor Ctr, Changhua, Taiwan
[8] Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan
[9] Cardinal Tien Hosp, Breast Surg Ctr, Dept Surg, Div Gen Surg, Taipei, Taiwan
[10] Wuri Lin Shin Hosp, Dept Surg, Taichung, Taiwan
[11] Kaohsiung Med Univ, Kaohsiung, Taiwan
[12] 135 Nanxiao St, Changhua 500, Taiwan
[13] 362 Zhongzheng Rd, New Taipei 23148, Taiwan
[14] 168 Ronghe Rd, Taichung 414, Taiwan
来源
EJSO | 2018年 / 44卷 / 11期
关键词
Breast cancer; Surgical margin; Magnetic resonance imaging (MRI); Breast-conserving surgery (BCS); Mastectomy; Ductal carcinoma in situ; CONSERVING SURGERY; POSITIVE MARGINS; RE-EXCISION; LOCAL RECURRENCE; LOBULAR CARCINOMA; ADEQUATE MARGIN; TUMOR SIZE; REEXCISION; LUMPECTOMY; BIOPSY;
D O I
10.1016/j.ejso.2018.07.056
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate whether clinicopathologic factors are related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer. Methods: Identification of patients at increased risk for positive surgical margins may enhance clinical preoperative decision-making and lower the reoperation rate. In this retrospective study, we analyzed the factors associated with positive surgical margins, the need for re-excision, and residual cancer detection in re-excised specimens in a cohort of 2050 women who underwent either breast-conserving surgery (BCS) or mastectomy for primary operable breast cancer. Results: Positive surgical margins were detected in 151 (7.4%) of the 2050 patients. The incidence of positive surgical margins was 11.3% (118/1042) in the BCS group and 33% (33/1008) in the mastectomy group (P < 0.001). In multivariate analysis, lower body mass index (BMI), larger tumor size, and pathologic evidence of multifocal disease were associated with positive surgical margin involvement in the BCS group. Younger age and ductal carcinoma in situ (DCIS) histologic subtypes (Odds ratio (OR) = 2.165, 95% CI = 1.253-4323) were associated with higher risk of re-operations. Preoperative MRI examination was associated with decreased risk for margin involvement in the BCS group (OR = 0.530, 95% CI = 0.332-0.842) and reoperation (OR = 0.302, 95% CI = 0.119-0.728). DCIS histologic subtypes were associated with higher residual tumor incidence than other types of breast cancer. Conclusions: Lower BMI, larger tumor size, pathologic evidence of multifocal disease, and no preoperative MRI evaluation were associated with increased risk for positive surgical margin involvement. DCISwith positive surgical margins was associated with increased risk for reoperation and residual cancer detection at re-excision. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1725 / 1735
页数:11
相关论文
共 50 条
  • [41] Analysis of related factors of surgical treatment effect on 215 patients with laryngeal cancer
    Zhang, Qiong
    Xiong, Ying
    Lin, Ling
    Yuan, Kun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (03) : 2786 - 2791
  • [42] Prognostic factors among elderly patients with operable non-metastatic breast cancer treated with primary endocrine therapy
    Rocha, Erika Andrade
    Vasconcellos, Jessica Monteiro
    Mendes, Sofia Vidaurre
    Freire, Pedro Jose Galvao
    Messias, Ana Paula
    Leis, Leticia Vecchi
    Moreira, Otavio Noschang
    Pereira, Mauricio Baptista
    Orsi, Bruna Zanin
    Araujo Neto, Augusto
    Petry, Vanessa
    Bonadio, Renata Colombo
    Testa, Laura
    CANCER RESEARCH, 2023, 83 (05)
  • [43] RANDOMIZED STUDY OF PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER - PRELIMINARY-RESULTS WITH 170 BREAST-CANCER PATIENTS
    DURAND, M
    MAURIAC, L
    PIGNEUX, J
    AVRIL, A
    DILHUYDY, JM
    MAREE, D
    BULLETIN DU CANCER, 1988, 75 (07) : 656 - &
  • [44] Clinicopathologic factors predicting involvement of non sentinel axillary lymphnodes in breast cancer patients: is axillary dissection always indicated?
    Scomersi, Serena
    Da Pozzo, Francesca
    Torelli, Lucio
    Zanconati, Fabrizio
    Tonutti, Maura
    Dore, Franca
    Bortul, Marina
    ANNALI ITALIANI DI CHIRURGIA, 2010, 81 (05) : 335 - 341
  • [45] The Analysis of Surgical Outcomes in Operable Gastric Cancer Patients Presenting With or Without Sarcopenia
    Supratim Bhattacharyya
    Padmalaya Devi
    Prafulla Kumar Das
    Subrat Samantara
    Kunhi Mohammed KP
    Snehasis Pradhan
    Muhammed Navas NK
    Indian Journal of Surgical Oncology, 2022, 13 : 511 - 515
  • [46] The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer
    Kaas, R
    Hart, AAM
    Rutgers, EJT
    BREAST, 2005, 14 (04): : 310 - 316
  • [47] Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
    Powles, T
    Paterson, S
    Kanis, JA
    McCloskey, E
    Ashley, S
    Tidy, A
    Rosenqvist, K
    Smith, I
    Ottestad, L
    Legault, S
    Pajunen, M
    Nevantaus, A
    Männistö, E
    Suovuori, A
    Atula, S
    Nevalainen, J
    Pylkkänen, L
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3219 - 3224
  • [48] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    J-Y Pierga
    E Mouret
    V Diéras
    V Laurence
    P Beuzeboc
    T Dorval
    T Palangié
    M Jouve
    A Vincent-Salomon
    S Scholl
    J-M Extra
    B Asselain
    P Pouillart
    British Journal of Cancer, 2000, 83 : 1480 - 1487
  • [49] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    Pierga, JY
    Mouret, E
    Diéras, V
    Laurence, V
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Vincent-Salomon, A
    Scholl, S
    Extra, JM
    Asselain, B
    Pouillart, P
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1480 - 1487
  • [50] The Analysis of Surgical Outcomes in Operable Gastric Cancer Patients Presenting With or Without Sarcopenia
    Bhattacharyya, Supratim
    Devi, Padmalaya
    Das, Prafulla Kumar
    Samantara, Subrat
    Mohammed, Kunhi K. P.
    Pradhan, Snehasis
    Navas, Muhammed N. K.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 13 (03) : 511 - 515